ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.1854del (p.Gly619fs)

dbSNP: rs1807328785
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Fulgent Genetics, Fulgent Genetics RCV001536023 SCV001752713 pathogenic Polycystic kidney disease 4 2021-06-30 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001873799 SCV002243488 pathogenic Autosomal recessive polycystic kidney disease 2023-04-18 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1179144). This premature translational stop signal has been observed in individual(s) with clinical features of polycystic kidney disease (PMID: 15805161, 27225849, 30650191). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly619Alafs*3) in the PKHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKHD1 are known to be pathogenic (PMID: 19940839).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.